The effects of JAM-A overexpression and silencing on HER3 gene or protein expression were reproduced in SK-BR-3 and MDA-MB-231 breast cancer cells (overexpression in Figure S3, silencing in Figure S4). Here, ERBB3 is linked to breast cancer.